Pfizer is inviting organizations to participate in an independent medical education initiative aimed at addressing critical knowledge gaps among healthcare professionals managing adults with moderately to severely active ulcerative colitis who are starting sphingosine 1-phosphate receptor modulator (S1Prm) therapy. Focus areas include understanding the role of electrocardiogram (ECG) and conduction assessment for patient selection, performing […]
Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members: